Manvir Victor’s Post

🌟 Exciting News in Kidney Disease Management! 🌟 📚 Just Released: A Comprehensive Guidance Document on Chronic Kidney Disease (CKD) Management 🔍 Multinational population studies based on CKD-PC 2023 analyses highlight the incremental increase in the association of all CKD complications with worse categories of estimated glomerular filtration rate (eGFR) and albuminuria. 💡 Key Highlights: -Emphasis on the importance of detecting CKD early, especially in high-risk populations. -Recommendations for accurate assessment of GFR and urine albumin-to-creatinine ratio (ACR). -Importance of using validated risk equations to estimate absolute risk of kidney failure. -Comprehensive discussion on delaying CKD progression and managing complications. -Insights into cardiovascular risk factor modification and drug stewardship in CKD. -Optimal models of care, including the value of multidisciplinary teams and advanced care planning. 🔬 Newer data on treating hyperuricemia were evaluated, with no support for targeting hyperuricemia in the absence of symptoms. 📊 Tables provided for "expected" values for common laboratory tests by eGFR to aid in identifying aberrant values. 🚀 Conclusion: This guidance document offers exciting new approaches to CKD management, aiming to improve symptom management, disease modification, and person-centered care. #KidneyDisease #CKDManagement #Healthcare #MedicalResearch #PatientCare #HealthTech #Nephrology #ChronicDiseaseManagement

The KDIGO 2024 CKD Guidebline Executive Summary.

It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.

The KDIGO 2024 CKD Guidelines are here! This is a major update to the 2012 guidelines which have guided CKD management for many years. Great job KDIGO on synthesizing the latest evidence to guide nephrologists in CKD care!

Mycetoma occurs in multiple countries across the ‘mycetoma belt’, which stretches across five continents between the latitudes of 15° S and 30° N. The fungal version of #mycetoma, known as eumycetoma, can cause severe deformities, disability, and mental health issues due to the stigma associated with the chronic, unrelenting course of the disease and lack of effective treatment, which often leads to amputation. Join us in this webinar with Drugs for Neglected Diseases initiative - DNDi and Centers for Disease Control and Prevention during Fungal Disease Awareness Week as we bring together healthcare experts and advocates to discuss diagnosis, treatment, and research progress. Register here: https://bit.ly/3AVs2I5 #FungalWeek24

Raise awareness this Rheumatological Diseases Awareness Month. Know the symptoms, share knowledge, and support those affected. #RheumAwareness #FightRheumatology #RheumatologicalDiseases #KnowTheSigns #AsterBangalore #AsterHospitals

May is CIDP Awareness Month – chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating condition that affects the nerves, leading to muscle weakness. Diagnosis can be challenging, often taking months or even years, further delaying effective treatment and disease management. We remain committed to addressing the unmet needs of those living with #CIDP and helping to spread awareness and education. #GBSCIDPAwarenessMonth #CIDPAwarenessMonth #PlasmaDerivedTherapies #Plasma #RareDisease #CIDP

July is #GravesDiseaseAwarenessMonth. Thyroid Eye Disease (TED) is a prevalent comorbidity of Graves' Disease and can significantly impact a patient’s quality of life due to visual impairment and pain. The Endocrine Society shares insight into why individuals with #GravesDisease are prone to developing TED here. https://lnkd.in/gSy3gKJw

Chronic Kidney Disease (#CKD) has emerged as one of the most prominent causes of death in the 21st century. It is a progressive condition that affects 13.4% of the general population, accounting for over 800 million individuals worldwide with between 4.90 and 7.08 million patients with end-stage kidney disease (#ESKD) needing kidney replacement therapy. March being the National Kidney Month, we invite you to join us for a discussion on “Kidney disease: Burden, determinants and prevention”. Let’s get to know the actual state of CKD in Africa and propose possible recommendations in attaining a better CKD management in Africa. Date: 27 March, 2024 Time: 3:00pm (GMT+1) Register: https://lnkd.in/exreUcxa

Proclaimed in 1998 by the Global Initiative for Asthma, 𝗪𝗼𝗿𝗹𝗱 𝗔𝘀𝘁𝗵𝗺𝗮 𝗗𝗮𝘆 commemorates the more than 260 million people affected by one of the most widespread chronic diseases in the world. 🩺 This year's theme "𝗔𝘀𝘁𝗵𝗺𝗮 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝘀" emphasizes the importance of professional treatment of lung diseases, as around 450,000 people die of it every year - most of these deaths are preventable. 🫁 Clinical studies pave the way for enhanced understanding and effective management of chronic lung conditions like #asthma, thereby fostering successful treatment outcomes. #WorldAsthmaDay #AsthmaEducationEmpowers #ClinicalStudies #MedicalResearch